地产预期改善，关注家居估值修复弹性

Investment Rating - The report maintains an "Outperform" rating for the industry [4] Core Insights - The home furnishing sector is currently at a historical low in valuation, with expectations for recovery driven by improving real estate sentiment and policy expectations [3][5] - The report highlights specific companies for investment, including Gujia Home, Oppein Home, and Sophia, while also suggesting attention to undervalued stocks like Minda Holdings and Zhibang Home [3] - The report anticipates profit growth for Minda Holdings with projected net profits of HKD 2.07 billion, HKD 2.12 billion, and HKD 2.21 billion for FY2026 to FY2028, corresponding to PE ratios of 9X and 8X [3] - For Goodbaby International, projected net profits for 2025 to 2027 are HKD 150 million, HKD 344 million, and HKD 385 million, with a current valuation suggesting a potential for recovery [3] Summary by Sections Home Furnishing - The report notes a 14.6% year-on-year increase in retail sales of furniture for 2025, with a 2.2% decline in December [5] - Residential construction area decreased by 20.2% year-on-year for 2025, with a 20.6% decline in December [5] - The report emphasizes the low valuation and institutional holdings in the home furnishing sector, suggesting a potential for valuation recovery [5] Paper and Packaging - As of January 23, 2026, prices for various paper products have shown a decline, with white cardboard down by 5 CNY/ton and boxboard down by 52.8 CNY/ton [8] - The report indicates that major paper companies are planning to increase prices by 200 CNY/ton in late February to early March [8] - The report recommends companies with strong domestic production capabilities, such as Nine Dragons Paper and Sun Paper, for investment [8] Consumer Goods - The report highlights a 9.0% year-on-year increase in retail sales for sports and entertainment products in December [5] - The consumer goods sector is expected to benefit from expanding channels and product price increases, particularly in oral care and medical products [5] - The report suggests investment opportunities in companies like Anta, Li Ning, and 361 Degrees, which are expected to perform well in the current market [5]